Global X Genomics & Biotechnology ETF Rating $64.97 -0.71 (-1.08%) As of 04:00 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOptions ChainOwnershipRatings Global X Genomics & Biotechnology ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GNOM Aggregate RatingModerate Buy 2.62Holdings in GNOM have an aggregate rating of Moderate Buy based on 430 analyst ratings issued in the past year covering 24 companies (80.9% of the portfolio).GNOM Aggregate Price Target$64.59-0.04% DownsideHigh Prediction$64.59Average Prediction$64.59Low Prediction$64.59Holdings in GNOM have an aggregate price target of $64.59 and a range of $64.59 to $64.59 covering 24 companies (80.9% of the portfolio).GNOM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Genomics & Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 GNOM Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.98%TWSTTwist Bioscience$128.71-1.7%1.6723 of 5 stars2.70$98.30 -23.6%10Positive News5.77%GHGuardant Health$161.04-1.2%3.16 of 5 stars2.96$183.78 14.1%25Analyst Forecast5.44%TXG10x Genomics$63.22+2.5%1.382 of 5 stars2.24$40.57 -35.8%17Analyst Forecast4.90%NTRANatera$327.67+0.8%2.5118 of 5 stars2.82$319.38 -2.5%22Positive News4.81%ILMNIllumina$221.66+3.9%2.1527 of 5 stars2.39$191.31 -13.7%18Positive NewsAnalyst Forecast4.09%BMRNBioMarin Pharmaceutical$66.43-0.8%4.8935 of 5 stars2.74$89.17 34.2%23Analyst Forecast4.06%TECHBio-Techne$72.45+0.2%3.4534 of 5 stars2.12$68.92 -4.9%17Positive News3.85%ARWRArrowhead Pharmaceuticals$86.49+1.3%2.1071 of 5 stars2.62$98.42 13.8%13News CoverageAnalyst Forecast3.80%VRTXVertex Pharmaceuticals$557.96+0.2%3.637 of 5 stars2.96$569.52 2.1%23Positive NewsAnalyst Forecast3.74%MRNAModerna$148.87-1.3%1.4947 of 5 stars2.08$76.72 -48.5%24Trending NewsAnalyst DowngradeInsider TradeOptions VolumeAnalyst RevisionGap Down3.57%PRAXPraxis Precision Medicines$355.15-0.7%3.198 of 5 stars2.95$585.95 65.0%21Positive News3.53%QGENQiagen$43.80-0.9%2.675 of 5 stars2.43$43.93 0.3%143.12%CRSPCRISPR Therapeutics$56.49-0.8%2.4599 of 5 stars2.61$68.06 20.5%18News CoverageAnalyst Forecast2.82%BNTXBioNTech$102.88-0.9%3.1907 of 5 stars2.74$127.44 23.9%19Analyst Forecast2.75%VCYTVeracyte$44.67-0.5%4.3857 of 5 stars2.82$54.33 21.6%11Positive News2.58%LEGNLegend Biotech$21.75-0.6%3.2007 of 5 stars2.47$52.29 140.4%15Analyst Upgrade2.31%QUREuniQure$44.86-3.0%3.0952 of 5 stars2.76$65.00 44.9%17Trending NewsAnalyst Forecast2.25%CAICaris Life Sciences$25.32+2.1%2.6237 of 5 stars2.50$26.33 4.0%12Positive NewsHigh Trading Volume2.13%BEAMBeam Therapeutics$29.46+0.6%2.2697 of 5 stars2.69$49.00 66.3%13Positive News2.12%RAREUltragenyx Pharmaceutical$14.85-44.0%2.8719 of 5 stars2.57$37.53 152.7%21Trending NewsAnalyst DowngradeOptions VolumeGap DownHigh Trading Volume2.09%LLYEli Lilly and Company$1,160.98+0.1%4.9339 of 5 stars2.83$1,292.18 11.3%30Trending NewsAnalyst Upgrade1.78%CDNACareDx$49.86+0.5%3.6583 of 5 stars2.63$51.20 2.7%8Positive NewsAnalyst Forecast1.72%WGSGeneDx$87.39+0.8%2.474 of 5 stars2.89$89.57 2.5%9Positive News1.71%GILDGilead Sciences$151.22+1.1%3.8751 of 5 stars2.87$158.04 4.5%30Trending NewsAnalyst UpgradeInsider TradeAnalyst Revision This page (NASDAQ:GNOM) was last updated on 9/3/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
